DONUT Nearsightedness Study In Children and Metabolites Being Biomarkers For Glaucoma

Dr. David Berntsen (University of Houston - Houston, TX)

Dr. Pawan Singh (University of Missouri - Columbia, MO)

 Dr. David Berntsen, Clinical Sciences Department Chair and Golden-Golden Professor, College of Optometry, University of Houston, explains a clinical trial using atropine eye drops in the Delaying the Onset of Nearsightedness Until Treatment (DONUT) study.

Then, Dr. Pawan Singh, Assistant Professor of Ophthalmology, University of Missouri School of Medicine, discusses how the metabolites, agmatine and thiamine, could be biomarkers in the early diagnosis and treatment of glaucoma.

10/12/2025 Podcast (Click Image Below)